Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Complete Malaria Genomes Could Improve Species Identification and Surveillance

By LabMedica International staff writers
Posted on 16 Nov 2026

Malaria remains a major global health challenge, with an estimated 282 million cases and 610,000 deaths worldwide in 2024. More...

Although most research has focused on Plasmodium falciparum, Plasmodium ovale and Plasmodium malariae also infect millions of people. These neglected species have been difficult to study because long-term laboratory culture methods are not established and existing genetic references have been incomplete. New findings now provide complete genome assemblies generated directly from patient blood samples.

Researchers at the Wellcome Sanger Institute and collaborating institutions developed complete, chromosome-level reference genomes for P. ovale, P. malariae, and P. falciparum directly from natural human infections without laboratory culturing. Blood samples were collected from study participants with malaria in Faladie, Mali, in West Africa. The work involved the Parasites and Microbe Research and Training Center in Mali and other collaborating institutions.

The method used low-input DNA sequencing directly from patient blood. Researchers first increased the proportion of parasite genetic material by filtering out human white blood cells and uninfected red blood cells. They then used long-read sequencing to read large stretches of genetic code from as little as two nanograms of DNA. This was combined with Hi-C, a technique that maps the physical and three-dimensional organization of the genome, to assemble the DNA into complete chromosomes.

The study produced the most complete chromosome-level reference genomes to date for P. ovale and P. malariae, alongside P. falciparum. The approach also resolved previously unmapped chromosome ends containing repetitive DNA regions that encode proteins involved in immune evasion. In P. ovale wallikeri, the PIR gene family was found to contain more than 2,000 genes, accounting for roughly 25% of the parasite genome.

Comparisons across individual patient samples collected in the same region and during the same period also revealed extensive DNA recombination at chromosome ends. The findings were published November 12 in PLOS Pathogens. According to the study, these reference genomes could support more accurate molecular surveillance, analysis of parasite genetic diversity and malaria transmission, and discovery of therapeutic targets, while helping incorporate non-falciparum malaria parasites into broader elimination strategies.

"As our study draws on parasites sampled directly from patient infections, it reflects the genomic diversity of parasite populations as they actually occur in hosts in an endemic setting. Uncovering these full genomes revealed the extent of expansions of gene families sitting at the ends of chromosomes, which regularly shuffle genetic material to adapt and evade the human immune system," said Dr. Sunil Dogga, first author formerly at the Wellcome Sanger Institute and now senior scientific collaborator at the Swiss Tropical and Public Health Institute.

“This milestone was only possible thanks to the long-standing international collaboration between our team in Mali and the genomic expertise at the Sanger Institute. The genomes developed through this partnership provide an essential toolkit for improving species identification across West Africa,” said Professor Abdoulaye Djimdé, honorary faculty at the Wellcome Sanger Institute and director of the Parasites and Microbes Research and Training Center, Mali.

Related Links
Wellcome Sanger Institute 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: iStock

AMP 2026 Underscores Molecular Testing’s Role in Precision Medicine for Women’s Health

Advances in molecular diagnostics are creating new opportunities to improve the detection of sexually transmitted infections, identify antibiotic resistance, and assess cancer recurrence risk in women.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.